Posts

Osanni Bio raises $190M to advance ophthalmology and cardiology pipeline, including dry AMD candidate

on

Bayer Returns to Pharma M&A with Up to $2.45B Acquisition of Perfuse Therapeutics

on

Aurion Biotech Appoints Marjan Farid, M.D., as Chair of Medical Advisory Board

on

Alkeus Pharmaceuticals Appoints Carlos Quezada-Ruiz as Chief Medical Officer

on

Zhongmou Therapeutics Reports First-in-Human Success of Optogenetic Gene Therapy ZM-02 for Retinitis Pigmentosa

on

FDA Grants Regeneron Two Eylea HD Approvals in One Day

on

Eli Lilly to Acquire Adverum Biotechnologies in Gene Therapy Deal; Captain T Cell Secures €20M Funding

on

Eli Lilly Strikes Multiple Deals for Ultra-Rare Eye Disease Gene Therapy and RNAi Partnerships

on

Dr. Andreas Wallnöfer Named to Optigo Biotherapeutics Board of Directors

on

Otsuka Acquires Asia-Pacific Rights to 4D Molecular Therapeutics' Retinal Gene Therapy 4D-150 for $85 Million

on

Lilly Expands Gene Therapy Presence with Acquisition of Adverum Biotechnologies

on

FDA Rejects Sydnexis Myopia Drug for Kids; Chugai to Buy Renalys for $98M Upfront

on

Diorasis Therapeutics Welcomes Dr. Dimitri Azar to Its Board of Directors

on

Fierce Biotech Fundraising Tracker '25: Avenzo adds $60M Series B; Ollin debuts with $100M

on

Regeneron and Sandoz Settle Eylea Biosimilar Patent Dispute

on

Kowa Secures Expanded Rights to Nicox's Glaucoma Drug NCX 470 in Major Global Deal

on

Surrozen sets its sights on ophthalmology after binning liver programme

on